These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1530601)

  • 1. Synthesis and theoretical conformational studies of gonadotropin-releasing hormone analogs containing tetrahydroisoquinoline carboxylic acid.
    Koerber SC; Ibea M; Hagler AT; Rivier CL; Rivier JE
    Biochem Biophys Res Commun; 1992 Sep; 187(2):1035-41. PubMed ID: 1530601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone antagonists: novel members of the azaline B family.
    Rivier JE; Jiang G; Porter J; Hoeger CA; Craig AG; Corrigan A; Vale W; Rivier CL
    J Med Chem; 1995 Jul; 38(14):2649-62. PubMed ID: 7629804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone antagonists with N omega-triazolylornithine, -lysine, or -p-aminophenylalanine residues at positions 5 and 6.
    Rivier J; Porter J; Hoeger C; Theobald P; Craig AG; Dykert J; Corrigan A; Perrin M; Hook WA; Siraganian RP
    J Med Chem; 1992 Nov; 35(23):4270-8. PubMed ID: 1280300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of potent cyclic gonadotropin releasing hormone antagonists.
    Rivier J; Kupryszewski G; Varga J; Porter J; Rivier C; Perrin M; Hagler A; Struthers S; Corrigan A; Vale W
    J Med Chem; 1988 Mar; 31(3):677-82. PubMed ID: 3279211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational analysis of a highly potent dicyclic gonadotropin-releasing hormone antagonist by nuclear magnetic resonance and molecular dynamics.
    Bienstock RJ; Rizo J; Koerber SC; Rivier JE; Hagler AT; Gierasch LM
    J Med Chem; 1993 Oct; 36(22):3265-73. PubMed ID: 8230116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR studies on the structure of some cyclic and linear antagonists of luteinizing hormone-releasing hormone (LHRH).
    Reddy DV; Jagannadh B; Dutta AS; Kunwar AC
    Int J Pept Protein Res; 1995 Jul; 46(1):9-17. PubMed ID: 7558603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer simulation of the free energy of peptides with the local states method: analogues of gonadotropin releasing hormone in the random coil and stable states.
    Meirovitch H; Koerber SC; Rivier JE; Hagler AT
    Biopolymers; 1994 Jul; 34(7):815-39. PubMed ID: 8054467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative potencies of antagonists of the luteinizing hormone releasing hormone with Lys8 and Arg8 and substitutions in positions 3, 5, 6, 7 and 8.
    Folkers K; Bowers C; Tang PF; Kobota M; Xiao SB; Bender W; Liu YZ
    Z Naturforsch C J Biosci; 1986; 41(11-12):1087-91. PubMed ID: 2437717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of C alpha-methyl substitution on the conformation of linear GnRH antagonist analogs.
    Liff MI; Kopple KD; Tian Z; Roeske RW
    Int J Pept Protein Res; 1994 May; 43(5):471-6. PubMed ID: 8070971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased potency of antagonists of the luteinizing hormone releasing hormone which have D-3-Pal in position 6.
    Folkers K; Bowers C; Xiao SB; Tang PF; Kubota M
    Biochem Biophys Res Commun; 1986 Jun; 137(2):709-15. PubMed ID: 2425802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2.
    Wilkes BC; Schiller PW
    Biopolymers; 1994 Sep; 34(9):1213-9. PubMed ID: 7948733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformation-function relationships in LHRH analogs. I. Conformations of LHRH peptide backbone.
    Nikiforovich GV; Marshall GR
    Int J Pept Protein Res; 1993 Aug; 42(2):171-80. PubMed ID: 8407111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constrained phenylalanine analogues. Preferred conformation of the 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic) residue.
    Valle G; Kazmierski WM; Crisma M; Bonora GM; Toniolo C; Hruby VJ
    Int J Pept Protein Res; 1992; 40(3-4):222-32. PubMed ID: 1335996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased histamine release by luteinizing hormone-releasing hormone antagonists obtained upon translocation of the cationic amino acid from position 8 to position 7.
    Flouret G; Mahan K; Majewski T
    J Med Chem; 1992 Feb; 35(4):636-40. PubMed ID: 1371810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution and solid-state structure of the diketopiperazine of tyrosyl-tetrahydroisoquinoline-3-carboxylic acid.
    Ciajolo MR; Balboni G; Picone D; Salvadori S; Tancredi T; Temussi PA; Tuzi A
    Int J Pept Protein Res; 1995 Aug; 46(2):134-8. PubMed ID: 8567167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of potent dicyclic (4-10/5-8) gonadotropin releasing hormone (GnRH) antagonists.
    Rivier JE; Struthers RS; Porter J; Lahrichi SL; Jiang G; Cervini LA; Ibea M; Kirby DA; Koerber SC; Rivier CL
    J Med Chem; 2000 Mar; 43(5):784-96. PubMed ID: 10715147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of biologically active, conformationally constrained GnRH antagonists.
    Struthers RS; Tanaka G; Koerber SC; Solmajer T; Baniak EL; Gierasch LM; Vale W; Rivier J; Hagler AT
    Proteins; 1990; 8(4):295-304. PubMed ID: 2091022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin releasing hormone antagonists: novel structures incorporating N omega-cyano modified guanidine moieties.
    Rivier J; Theobald P; Porter J; Perrin M; Gunnet J; Hahn DW; Rivier C
    Biochem Biophys Res Commun; 1991 Apr; 176(1):406-12. PubMed ID: 1850267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of monocyclic (1-3) and dicyclic (1-3/4-10) gonadotropin releasing hormone (GnRH) antagonists.
    Rivier JE; Porter J; Cervini LA; Lahrichi SL; Kirby DA; Struthers RS; Koerber SC; Rivier CL
    J Med Chem; 2000 Mar; 43(5):797-806. PubMed ID: 10715148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.